Case – Orlistat-induced calcium oxalate crystalluria

Auteurs-es

  • Greta Handing Baylor College of Medicine
  • Ujval Ishu Pathak Department of Urology, Medical College of Wisconsin
  • Adithya Balasubramanian Department of Urology, Weill Cornell Medicine/New York Presbyterian
  • Alexander Liu Department of Urology, Baylor College of Medicine
  • Wesley A. Mayer Department of Urology, Baylor College of Medicine

DOI :

https://doi.org/10.5489/cuaj.7900

Mots-clés :

kidney stone, orlistat, hyperoxaluria, nephrolithiasis, supplements

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Publié-e

2022-05-20

Comment citer

Handing, G., Pathak, U. I. ., Balasubramanian, A. ., Liu, A. ., & Mayer, W. A. (2022). Case – Orlistat-induced calcium oxalate crystalluria. Canadian Urological Association Journal, 16(10), 371–3. https://doi.org/10.5489/cuaj.7900

Numéro

Rubrique

Residents' Room